AGF US Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Share price up 0.3%

Shares of the AGF US Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) rose 0.3% on Friday. The company was trading at $19.27 and last traded at $19.17. About 215,786 shares changed hands during midday trading, down 20% from average daily volume of 269,558 shares. Shares had previously closed at $19.12.

Stocks of the AGF US Market Neutral Anti-Beta fund increase by 0.3%

The company has a fifty-day simple moving average of $18.64 and a two-hundred-day simple moving average of $18.62. The company has a market capitalization of $274.13 million, a P/E ratio of 15.45 and a beta of -0.85.

Institutional trading of the AGF US Market Neutral Anti-Beta Fund

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vermillion & White Wealth Management Group LLC acquired a new stake in AGF US Market Neutral Anti-Beta Fund during the fourth quarter worth approximately $1,190,000. Worth Asset Management LLC increased its position in shares of AGF US Market Neutral Anti-Beta Fund by 26.4% during the fourth quarter. Worth Asset Management LLC now owns 51,594 shares of the company’s stock valued at $875,000 after purchasing an additional 10,792 shares in the last quarter. VitalStone Financial LLC increased its position in shares of AGF US Market Neutral Anti-Beta Fund by 883.2% during the first quarter. VitalStone Financial LLC now owns 27,481 shares of the company’s stock valued at $495,000 after purchasing an additional 24,686 shares in the last quarter. Triumph Capital Management acquired a new stake in shares of AGF US Market Neutral Anti-Beta Fund during the first quarter valued at approximately $474,000. Finally, Toronto Dominion Bank increased its position in shares of AGF US Market Neutral Anti-Beta Fund by 352.8% during the first quarter. Toronto Dominion Bank now owns 3,930 shares of the company’s stock valued at $71,000 after purchasing an additional 3,062 shares in the last quarter.

About the AGF US Market Neutral Anti-Beta fund

(Get the free report)

AGFiQ US Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that invests primarily in alternative long and F positions. The Fund is an actively managed fund that has long positions in low-beta US equities, offset by short positions in US stocks with high beta. BTAL was launched on September 13, 2011 and is managed by AGF.

Stocks of the AGF US Market Neutral Anti-Beta fund increase by 0.3%

Institutional trading of the AGF US Market Neutral Anti-Beta Fund

About the AGF US Market Neutral Anti-Beta fund

See also